Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Karyopharm Therapeutics Inc. buy Piper Sandler

Karyopharm Therapeutics Inc.
Start price
€0.54
17.12.25 / 50%
Target price
-
17.12.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 17.12.26. The prediction end date can be changed by Piper_Sandler at any time.
Performance without dividends (%)
Name 1w
Karyopharm Therapeutics Inc. -
iShares Core DAX® 0.323%
iShares Nasdaq 100 0.145%
iShares Nikkei 225® 0.091%
iShares S&P 500 0.371%

Comments by Piper_Sandler for this prediction

In the thread Karyopharm Therapeutics Inc. diskutieren

Karyopharm Therapeutics (NASDAQ:KPTI) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Ratings data for KPTI provided by MarketBeat

Piper Sandler 
0
Report Share
17.12.25 Buy -

Stopped prediction by Piper_Sandler for Karyopharm Therapeutics Inc.

buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.54
09.10.25
€10.31
09.10.26
-
25.02.25

Piper Sandler 
09.10.25 50%
buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.83
06.11.24
€4.67
06.11.25
-33.98%
07.11.25

Piper Sandler 
06.11.24 50%